We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) closed the most recent trading day at $186.55, moving -1.13% from the previous trading session. This change lagged the S&P 500's daily loss of 0.75%. At the same time, the Dow lost 0.32%, and the tech-heavy Nasdaq lost 0.11%.
Coming into today, shares of the company had lost 14.75% in the past month. In that same time, the Medical sector lost 4.88%, while the S&P 500 lost 8.4%.
Investors will be hoping for strength from Intuitive Surgical, Inc. as it approaches its next earnings release, which is expected to be October 18, 2022. The company is expected to report EPS of $1.10, down 7.56% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 8.94% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.56 per share and revenue of $6.2 billion, which would represent changes of -8.06% and +8.6%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Intuitive Surgical, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Digging into valuation, Intuitive Surgical, Inc. currently has a Forward P/E ratio of 41.4. This represents a premium compared to its industry's average Forward P/E of 24.91.
Meanwhile, ISRG's PEG ratio is currently 4.34. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments industry currently had an average PEG ratio of 1.82 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 132, which puts it in the bottom 48% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) closed the most recent trading day at $186.55, moving -1.13% from the previous trading session. This change lagged the S&P 500's daily loss of 0.75%. At the same time, the Dow lost 0.32%, and the tech-heavy Nasdaq lost 0.11%.
Coming into today, shares of the company had lost 14.75% in the past month. In that same time, the Medical sector lost 4.88%, while the S&P 500 lost 8.4%.
Investors will be hoping for strength from Intuitive Surgical, Inc. as it approaches its next earnings release, which is expected to be October 18, 2022. The company is expected to report EPS of $1.10, down 7.56% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 8.94% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.56 per share and revenue of $6.2 billion, which would represent changes of -8.06% and +8.6%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Intuitive Surgical, Inc.These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Intuitive Surgical, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Digging into valuation, Intuitive Surgical, Inc. currently has a Forward P/E ratio of 41.4. This represents a premium compared to its industry's average Forward P/E of 24.91.
Meanwhile, ISRG's PEG ratio is currently 4.34. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments industry currently had an average PEG ratio of 1.82 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 132, which puts it in the bottom 48% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.